Article
Alphabet's AI drug startup Isomorphic Labs raises $5B
Isomorphic Labs has raised $5 billion in a Series C funding round led by Sequoia Capital and Greenoaks, Bloomberg reports. The Alphabet-owned startup led by Nobel laureate Demis Hassabis aims to develop new drugs using artificial intelligence. In a post on LinkedIn, Hassabis said Isomorphic is on track to "radically cut the time and cost to find new medicines." It is competing against other startups, including Chai Discovery, in a race to become the first biotech to launch an AI-designed drug that receives regulatory approval.
**Isomorphic Labs Raises $5 Billion as AI Drug Discovery Attracts Record Biotech Investment** Isomorphic Labs, the artificial intelligence drug discovery company owned by Alphabet, has raised $5 billion in a Series C funding round co-led by Sequoia Capital...
